| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,650 |
7,655 |
$1.09M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
550 |
497 |
$799K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,207 |
3,475 |
$450K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,829 |
1,602 |
$280K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,636 |
655 |
$261K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,194 |
936 |
$62K |
| 71045 |
Radiologic examination, chest; single view |
488 |
369 |
$53K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
783 |
696 |
$50K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
433 |
354 |
$37K |
| 80053 |
Comprehensive metabolic panel |
4,600 |
3,700 |
$27K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
439 |
386 |
$27K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
352 |
320 |
$23K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,768 |
3,868 |
$22K |
| 96367 |
|
313 |
122 |
$12K |
| 96523 |
|
184 |
123 |
$11K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
378 |
300 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
378 |
300 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
4,413 |
3,516 |
$8K |
| J7050 |
Infusion, normal saline solution, 250 cc |
221 |
74 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
96 |
85 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
198 |
175 |
$4K |
| 86769 |
|
121 |
113 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
61 |
42 |
$3K |
| 86003 |
|
21 |
15 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
29 |
26 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
136 |
121 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
110 |
64 |
$2K |
| 81025 |
|
352 |
302 |
$2K |
| 80061 |
Lipid panel |
251 |
219 |
$2K |
| 81001 |
|
759 |
629 |
$2K |
| 84484 |
|
258 |
139 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
285 |
123 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
232 |
196 |
$1K |
| 86780 |
|
124 |
109 |
$1K |
| 87660 |
|
86 |
78 |
$1K |
| 87510 |
|
86 |
78 |
$1K |
| 87480 |
|
86 |
78 |
$1K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
90 |
77 |
$998.01 |
| 87481 |
|
26 |
12 |
$714.51 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
134 |
110 |
$705.19 |
| 71046 |
Radiologic examination, chest; 2 views |
42 |
29 |
$670.88 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
20 |
12 |
$564.59 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
20 |
12 |
$504.36 |
| 83655 |
|
38 |
38 |
$487.09 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
19 |
12 |
$408.24 |
| 85027 |
|
141 |
110 |
$398.28 |
| 83735 |
|
91 |
65 |
$360.28 |
| 82785 |
|
19 |
13 |
$279.82 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
20 |
12 |
$263.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
22 |
14 |
$161.66 |
| 87081 |
|
13 |
13 |
$84.33 |
| 87430 |
|
13 |
12 |
$68.76 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,497 |
649 |
$66.18 |
| 83690 |
|
14 |
12 |
$59.45 |
| 82950 |
|
15 |
12 |
$16.93 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
324 |
267 |
$9.52 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
133 |
125 |
$1.10 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
357 |
319 |
$0.59 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
276 |
247 |
$0.00 |